TORONTO, ONTARIO--(Marketwired - Oct. 22, 2015) - Supreme Pharmaceuticals Inc. (the "Company") (OTC PINK:SPRWF)(CSE:SL) advises that it has settled outstanding debts by the issuance of 215,000 common shares at a weighted average price of $0.125 per share. These shares shall be subject to a 4 month trading restriction.

About Supreme

Supreme is a Canadian publically traded company committed to becoming a leading supplier of affordable medical cannabis achieved by applying commercial agriculture practices to medical cannabis production. Supreme's flagship facility is a 342,000 sq. ft. hybrid greenhouse located in Kincardine, Ontario, which has been designed to maximize production efficiencies allowing the Company to pass savings along to its future patients.

Contact Information:

Supreme Pharmaceuticals Inc.
Investor Relations
(416) 630-7272